Phoenix Dance: The Eldest Daughter's Physician Consort Shocks the World

Chapter 356 The Arrival of a New Disease and the Application of Results

Just as the "Medical Innovation Alliance" was making steady progress in its research in collaboration with European teams, a worrying piece of news shattered the brief calm.

"Miss Su, something terrible has happened! Recently, an unexplained disease has emerged in Southeast Asia. The symptoms are peculiar, and the disease is spreading extremely rapidly. The local medical system is already struggling to cope." The member in charge of intelligence gathering rushed over to report this emergency to Su Yao.

Su Yao's expression immediately turned serious. "What exactly are the symptoms? Tell me in detail quickly."

"Initially, patients will experience symptoms such as high fever and cough, followed by large areas of red rash on the skin. Subsequently, the condition deteriorates rapidly, and organ function will be severely affected," the member described anxiously.

Su Yao knew the situation was urgent. "Immediately summon all core members to discuss countermeasures. At the same time, contact local medical institutions in Southeast Asia to obtain more detailed patient information and disease progression."

The atmosphere in the meeting room of the "Medical New Alliance" was tense and heavy. "Everyone is aware of the situation. This newly emerging disease is spreading rapidly, and we must find a solution as soon as possible," Su Yao said.

“Master, should we suspend our current research project and devote all our efforts to the research on this new disease?” one member suggested.

Su Yao pondered for a moment, "Our current collaborative project with the European team is also crucial and cannot be completely shelved. We can allocate some resources to researching new diseases while maintaining the progress of the collaborative project."

Just as the "Medical New Alliance" was making intensive preparations to deal with the new disease, their research results in collaboration with European teams also reached a critical stage of application and promotion.

“Ms. Su, our research results have passed clinical trials and shown significant effects. The next step is to figure out how to extend their application to more patients,” the head of the European team said in a video conference.

Su Yao nodded in agreement, "That's right, but the promotion process will definitely not be smooth sailing. Different regions have different levels of medical care, economic conditions, and cultural backgrounds, so we need to develop a detailed promotion plan."

After several discussions, both parties decided to first conduct pilot programs in areas with relatively abundant medical resources and high acceptance rates. "We can first establish treatment centers in Europe and some major cities in China, so that patients can benefit first. At the same time, we will strengthen the training of medical staff to ensure that they can skillfully use our treatment plan," Su Yao proposed.

However, problems arose one after another during the pilot rollout. "Ms. Su, we found that some patients have concerns about our treatment plan during the rollout, worrying about potential side effects," the member in charge of the rollout reported.

Su Yao patiently explained, "This is normal, after all, it's a new treatment plan. We need to strengthen our outreach and explanation efforts to help patients understand the principles and safety of the treatment. We can invite some recovered patients to share their experiences to boost everyone's confidence."

Meanwhile, the team researching the new disease also made some initial progress. "Master, we analyzed patient samples and found that this disease is caused by a novel virus. We are trying to develop targeted drugs," a member of the research team excitedly reported.

Su Yao said with relief, "Very good, everyone keep up the good work. While developing drugs, we must also cooperate with local medical institutions to do a good job in prevention and control to prevent the disease from spreading further."

Under the dual tasks of responding to new disease threats and promoting the application of research results, the members of the "Medical Innovation Alliance" are busy day and night. They are well aware that they bear a great responsibility, and every decision is related to the lives and health of countless people.